Previous 10 | Next 10 |
Zynex is well positioned to capitalize on recent fundamental momentum in sales volume and top-line growth. Such momentum hasn't yet translated to share performance, and the market continues to discount Zynex shares. Questions around management's posture on inventory remain, and la...
Zynex ([[ZYXI]] -3.5%) announces Q1 order growth of 140% Y/Y, and confirms its previous revenue estimate 1Q21 of between $23M and $24.5M vs. consensus of $23.8M and Adj. EBITDA loss estimate of between $0.5M and $1.5M.FY21 revenue estimate is between $135M and $150M vs. consensus of $138.03M;...
Zynex Announces 140% Year over Year Order Growth in Q1-2021 PR Newswire ENGLEWOOD, Colo. , April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devi...
Zynex Growth Leads to New Corporate Headquarters PR Newswire ENGLEWOOD, Colo. , April 9, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...
Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado PR Newswire ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of n...
Zynex ([[ZYXI]] +4.4%) says it has received board approval to repurchase $10M of shares through expiry of Sep. 8, 2021."We believe that the current market value of our shares does not accurately reflect the underlying value of the Company and the buyback program represents an attractive oppor...
Zynex Announces Share Buyback Program PR Newswire ENGLEWOOD, Colo. , March 8, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manageme...
The following slide deck was published by Zynex, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Zynex, Inc. 2020 Q4 - Results - Earnings Call Presentation
Gainers: Xtant Medical (XTNT) +189%.Intrusion (INTZ) +33%.Armstrong Flooring (AFI) +28%.Just Energy Group (JE) +28%.AMC Networks (AMCX) +26%.Applied UV (AUVI) +24%.Fisker (FSR) +21%.Ocugen (OCGN) +20%.Select Medical (SEM) +19%.Rubius Therapeutics (RUBY) +19%.Losers: Tricid...
Shares of Zynex (NASDAQ: ZYXI) were crashing 17.8% lower as of 11:21 a.m. EST on Friday. The steep drop came after the medical technology company announced its fourth-quarter results following the market close on Thursday. It wasn't that Zynex's Q4 results were bad. The company ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...